FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jean Klastersky

Research Profile

Disorders

Procedures

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Jean Klastersky; Harry Raftopoulos; Bernardo Rapoport
The MASCC Neutropenia, Infection and Myelosuppression Study Group evaluates recent new concepts for the use of granulocyte colony-stimulating factors for the prevention of febrile neutropenia.
Jean Klastersky; Marianne Paesmans
The Multinational Association for Supportive Care in Cancer (MASCC) risk index score: 10 years of use for identifying low-risk febrile neutropenic cancer patients.
Jean Klastersky
From best supportive care to early palliative care.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jean Klastersky (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Jean Klastersky; Harry Raftopoulos; Bernardo Rapoport
The MASCC Neutropenia, Infection and Myelosuppression Study Group evaluates recent new concepts for the use of granulocyte colony-stimulating factors for the prevention of febrile neutropenia.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2013;21(6):1793-5.
2013: Jean Klastersky; Marianne Paesmans
The Multinational Association for Supportive Care in Cancer (MASCC) risk index score: 10 years of use for identifying low-risk febrile neutropenic cancer patients.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2013;21(5):1487-95.
2011: Jean Klastersky
From best supportive care to early palliative care.
Current opinion in oncology 2011;23(4):311-2.
2011: Marianne Paesmans; Bernardo Rapoport; Kenneth Rolston; Mickael Aoun; Augustin Ferrant; Aspasia Georgala; Jean Klastersky; Johan Maertens; Frédérique Muanza; Lieveke ameye
Predicting febrile neutropenic patients at low risk using the MASCC score: does bacteremia matter?
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2011;19(7):1001-8.
2011: Jean Klastersky; Ahmad Awada; Mariane Paesmans; Mickael Aoun
Febrile neutropenia: a critical review of the initial management.
Critical reviews in oncology/hematology 2011;78(3):185-94.
2011: Jean Klastersky; Ahmad Awada
Prevention of febrile neutropenia in chemotherapy-treated cancer patients: Pegylated versus standard myeloid colony stimulating factors. Do we have a choice?
Critical reviews in oncology/hematology 2011;78(1):17-23.
2010: Jean Klastersky
Supportive care: new trends and new needs.
Current opinion in oncology 2010;22(4):301.
2010: Isabelle Bragard; Yves Libert; Anne-Marie Etienne; Isabelle Merckaert; Nicole Delvaux; Serge Marchal; Jacques Boniver; Jean Klastersky; Christine Reynaert; Pierre Scalliet; Jean-Louis Slachmuylder; Darius Razavi
Insight on variables leading to burnout in cancer physicians.
Journal of cancer education : the official journal of the American Association for Cancer Education 2010;25(1):109-15.
2009: Jean Klastersky; Ahmad Awada; Michel Aoun; Marianne Paesmans
Should the indications for the use of myeloid growth factors for the prevention of febrile neutropenia in cancer patients be extended?
Current opinion in oncology 2009;21(4):297-302.
2009: Jean Klastersky
The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Why empirical therapy?
The Journal of antimicrobial chemotherapy 2009;63 Suppl 1():i14-5.
2008: M T Genot-Klastersky; Jean Klastersky; F Awada; Ahmad Awada; P Crombez; M D Martinez; M F Jaivenois; M Delmelle; G Vogt; Nathalie Meuleman; Marianne Paesmans
The use of low-energy laser (LEL) for the prevention of chemotherapy- and/or radiotherapy-induced oral mucositis in cancer patients: results from two prospective studies.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2008;16(12):1381-7.
2008: Aurore Lienard; Isabelle Merckaert; Yves Libert; Nicole Delvaux; Serge Marchal; Jacques Boniver; Anne-Marie Etienne; Jean Klastersky; Christine Reynaert; Pierre Scalliet; Jean-Louis Slachmuylder; Darius Razavi
Factors that influence cancer patients' and relatives' anxiety following a three-person medical consultation: impact of a communication skills training program for physicians.
Psycho-oncology 2008;17(5):488-96.
2008: Fanny Bauvet; Jean Klastersky; Ahmad Awada
[Supportive care in cancer: concepts, achievements and challenges].
Bulletin du cancer 2008;95(3):381-8.
2008: Isabelle Merckaert; Yves Libert; Nicole Delvaux; Serge Marchal; Jacques Boniver; Anne-Marie Etienne; Jean Klastersky; Christine Reynaert; Pierre Scalliet; Jean-Louis Slachmuylder; Darius Razavi
Factors influencing physicians' detection of cancer patients' and relatives' distress: can a communication skills training program improve physicians' detection?
Psycho-oncology 2008;17(3):260-9.
2007: Jean Klastersky; Lieveke ameye; Johan Maertens; Aspasia Georgala; Frédérique Muanza; Mickael Aoun; A Ferrant; B Rapoport; Kenneth Rolston; Marianne Paesmans
Bacteraemia in febrile neutropenic cancer patients.
International journal of antimicrobial agents 2007;30 Suppl 1():S51-9.
2007: Marc Vekemans; J Robinson; Aspasia Georgala; Corine Heymans; Frédérique Muanza; Marianne Paesmans; Jean Klastersky; Martine Barette; Nathalie Meuleman; F Huet; Thierry Calandra; S Costantini; A Ferrant; F Mathissen; M Axelsen; Oscar Marchetti; Mickael Aoun
Low mannose-binding lectin concentration is associated with severe infection in patients with hematological cancer who are undergoing chemotherapy.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007;44(12):1593-601.
2007: Yves Libert; Isabelle Merckaert; Christine Reynaert; Nicole Delvaux; Serge Marchal; Anne-Marie Etienne; Jacques Boniver; Jean Klastersky; Pierre Scalliet; Jean-Louis Slachmuylder; Darius Razavi
Physicians are different when they learn communication skills: influence of the locus of control.
Psycho-oncology 2007;16(6):553-62.
2007: Jean Klastersky; Marianne Paesmans
Risk-adapted strategy for the management of febrile neutropenia in cancer patients.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2007;15(5):477-82.
2007: Thierry Appelboom; Elie Cogan; Jean Klastersky
Job of the Bible: leprosy or scabies?
The Mount Sinai journal of medicine, New York 2007;74(1):36-9.
2007: Jean Klastersky; Marianne Paesmans
Antifungal therapy in febrile neutropenic patients: review of treatment choices and strategies for aspergillar infection.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2007;15(2):137-41.
2006: Jean Klastersky; Marianne Paesmans; Aspasia Georgala; Frédérique Muanza; Barbara Plehiers; Laurent Dubreucq; Yassine Lalami; Mickael Aoun; Martine Barette
Outpatient oral antibiotics for febrile neutropenic cancer patients using a score predictive for complications.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(25):4129-34.
2006: A Liénard; Isabelle Merckaert; Yves Libert; Nicole Delvaux; Serge Marchal; J Boniver; Anne-Marie Etienne; Jean Klastersky; Christine Reynaert; Pierre Scalliet; Jean-Louis Slachmuylder; Darius Razavi
Factors that influence cancer patients' anxiety following a medical consultation: impact of a communication skills training programme for physicians.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(9):1450-8.
2006: Jean Klastersky
Endocrine tumors of the pancreas.
Current opinion in oncology 2006;18(4):414.
2006: Jean Klastersky
Adverse effects of the humanized antibodies used as cancer therapeutics.
Current opinion in oncology 2006;18(4):316-20.
2006: Isabelle Bragard; Darius Razavi; Serge Marchal; Isabelle Merckaert; Nicole Delvaux; Yves Libert; Christine Reynaert; Jacques Boniver; Jean Klastersky; Pierre Scalliet; Anne-Marie Etienne
Teaching communication and stress management skills to junior physicians dealing with cancer patients: a Belgian Interuniversity Curriculum.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2006;14(5):454-61.
2006: Yassine Lalami; Marianne Paesmans; Frédérique Muanza; Martine Barette; B Plehiers; L Dubreucq; Aspasia Georgala; Jean Klastersky
Can we predict the duration of chemotherapy-induced neutropenia in febrile neutropenic patients, focusing on regimen-specific risk factors? A retrospective analysis.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(3):507-14.
2006: Yves Libert; Isabelle Merckaert; Christine Reynaert; Nicole Delvaux; Serge Marchal; Anne-Marie Etienne; Jacques Boniver; Jean Klastersky; Pierre Scalliet; Jean-Louis Slachmuylder; Darius Razavi
Does psychological characteristic influence physicians' communication styles? Impact of physicians' locus of control on interviews with a cancer patient and a relative.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2006;14(3):230-42.
2005: Jean Klastersky; A Awada
[New trends in the management of common solid malignant tumors].
Revue médicale de Bruxelles 2005;26(5):425-32.
2005: Isabelle Merckaert; Yves Libert; Nicole Delvaux; Serge Marchal; Jacques Boniver; Anne-Marie Etienne; Jean Klastersky; Christine Reynaert; Pierre Scalliet; Jean-Louis Slachmuylder; Darius Razavi
Factors that influence physicians' detection of distress in patients with cancer: can a communication skills training program improve physicians' detection?
Cancer 2005;104(2):411-21.
2005: Nicole Delvaux; Isabelle Merckaert; Serge Marchal; Yves Libert; Sandrine Conradt; Jacques Boniver; Anne-Marie Etienne; Ovide Fontaine; Pascal Janne; Jean Klastersky; Christian Mélot; Christine Reynaert; Pierre Scalliet; Jean-Louis Slachmuylder; Darius Razavi
Physicians' communication with a cancer patient and a relative: a randomized study assessing the efficacy of consolidation workshops.
Cancer 2005;103(11):2397-411.
2005: Marie-Thérèse Genot; Jean Klastersky
Low-level laser for prevention and therapy of oral mucositis induced by chemotherapy or radiotherapy.
Current opinion in oncology 2005;17(3):236-40.
2005: Ahmad Awada; Marie-Thérèse Genot; Jean Klastersky
Palifermin and chemotherapy-induced oral mucositis.
The New England journal of medicine 2005;352(12):1264-5; author reply 1264-5.
2004: Yassine Lalami; Marianne Paesmans; Mickael Aoun; R Munoz-Bermeo; K Reuss; S Cherifi; C G Alexopoulos; Jean Klastersky
A prospective randomised evaluation of G-CSF or G-CSF plus oral antibiotics in chemotherapy-treated patients at high risk of developing febrile neutropenia.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2004;12(10):725-30.
2004: Jean Klastersky
Antifungal therapy in patients with fever and neutropenia--more rational and less empirical?
The New England journal of medicine 2004;351(14):1445-7.
2004: Jean Klastersky
Management of fever in neutropenic patients with different risks of complications.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;39 Suppl 1():S32-7.
2004: Jean Klastersky
Empirical antifungal therapy.
International journal of antimicrobial agents 2004;23(2):105-12.
2004: Jean Klastersky; Mickael Aoun
Opportunistic infections in patients with cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15 Suppl 4():iv329-35.
2003: Darius Razavi; Isabelle Merckaert; Serge Marchal; Yves Libert; Sandrine Conradt; Jacques Boniver; Anne-Marie Etienne; Ovide Fontaine; Pascal Janne; Jean Klastersky; Christine Reynaert; Pierre Scalliet; Jean-Louis Slachmuylder; Nicole Delvaux
How to optimize physicians' communication skills in cancer care: results of a randomized study assessing the usefulness of posttraining consolidation workshops.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(16):3141-9.
2003: Alain Cometta; WV Kern; R De Bock; Marianne Paesmans; M Vandenbergh; Françoise Crokaert; D Engelhard; Oscar Marchetti; H Akan; A Skoutelis; V Korten; M Vandercam; H Gaya; A Padmos; Jean Klastersky; S Zinner; Michel-Pierre Glauser; Thierry Calandra; Claudio Viscoli
Vancomycin versus placebo for treating persistent fever in patients with neutropenic cancer receiving piperacillin-tazobactam monotherapy.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2003;37(3):382-9.
2003: Thierry Berghmans; Jean-Paul Sculier; Jean Klastersky
A prospective study of infections in lung cancer patients admitted to the hospital.
Chest 2003;124(1):114-20.
2003: Jean Klastersky
Use of imipenem as empirical treatment of febrile neutropenia.
International journal of antimicrobial agents 2003;21(5):393-402.
2003: Yves Libert; Pascal Janne; Darius Razavi; Isabelle Merckaert; Pierre Scalliet; Nicole Delvaux; Anne-Marie Etienne; Sandrine Conradt; Jean Klastersky; J Boniver; Christine Reynaert
Impact of medical specialists' locus of control on communication skills in oncological interviews.
British journal of cancer 2003;88(4):502-9.
2003: Jean Klastersky
Side effects of ifosfamide.
Oncology 2003;65 Suppl 2():7-10.
2002: Ronald Feld; Marianne Paesmans; Alison G Freifeld; Jean Klastersky; Philip A Pizzo; Kenneth V I Rolston; Edward B Rubenstein; James A Talcott; THOMAS WALSH
Methodology for clinical trials involving patients with cancer who have febrile neutropenia: updated guidelines of the Immunocompromised Host Society/Multinational Association for Supportive Care in Cancer, with emphasis on outpatient studies.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2002;35(12):1463-8.
2002: Jean-Paul Sculier; Jean-Jacques Lafitte; J Lecomte; Thierry Berghmans; J Thiriaux; O Van Cutsem; Anna P Efremidis; Vincent Ninane; Marianne Paesmans; P Mommen; Jean Klastersky
A phase II randomised trial comparing the cisplatin-etoposide combination chemotherapy with or without carboplatin as second-line therapy for small-cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(9):1454-9.
2002: Jean-Paul Sculier; Thierry Berghmans; Jean-Jacques Lafitte; M Richez; P Recloux; O Van Cutsem; Vincent Ninane; P Mommen; Marianne Paesmans; Jean Klastersky
A phase II study testing paclitaxel as second-line single agent treatment for patients with advanced non-small cell lung cancer failing after a first-line chemotherapy.
Lung cancer (Amsterdam, Netherlands) 2002;37(1):73-7.
2002: Jean-Paul Sculier; Jean-Jacques Lafitte; J Lecomte; Thierry Berghmans; J Thiriaux; MC Florin; Anna P Efremidis; CG Alexopoulos; P Recloux; Vincent Ninane; P Mommen; Marianne Paesmans; Jean Klastersky
A three-arm phase III randomised trial comparing combinations of platinum derivatives, ifosfamide and/or gemcitabine in stage IV non-small-cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(6):874-82.
2002: E Toussaint; K Reuss; Mickael Aoun; J Dagnelie; Jean-Marc Verdebout; Jean Klastersky
[Subcutaneous nodules and lung cavitated nodules].
Revue médicale de Bruxelles 2002;23(2):102-7.
2001: Jean Klastersky; Marianne Paesmans
Response to chemotherapy, quality of life benefits and survival in advanced non-small cell lung cancer: review of literature results.
Lung cancer (Amsterdam, Netherlands) 2001;34 Suppl 4():S95-101.
2001: Jean-Paul Sculier; Marianne Paesmans; J Lecomte; O Van Cutsem; Jean-Jacques Lafitte; Thierry Berghmans; George Koumakis; MC Florin; J Thiriaux; J Michel; V Giner; MC Berchier; P Mommen; Vincent Ninane; Jean Klastersky
A three-arm phase III randomised trial assessing, in patients with extensive-disease small-cell lung cancer, accelerated chemotherapy with support of haematological growth factor or oral antibiotics.
British journal of cancer 2001;85(10):1444-51.
2001: Mickael Aoun; Jean Klastersky
[Respiratory infections during chemotherapy-induced aplasia].
Revue des maladies respiratoires 2001;18(2):125-35.
2001: Jean Klastersky
Empirical treatment of sepsis in neutropenic patients.
Hospital medicine (London, England : 1998) 2001;62(2):101-3.
2000: Jean-Paul Sculier; Jean-Jacques Lafitte; Marianne Paesmans; J Thiriaux; CG Alexopoulos; J Baumöhl; J Schmerber; George Koumakis; MC Florin; Constantinos Zacharias; Thierry Berghmans; P Mommen; Vincent Ninane; Jean Klastersky
Phase III randomized trial comparing moderate-dose cisplatin to combined cisplatin and carboplatin in addition to mitomycin and ifosfamide in patients with stage IV non-small-cell lung cancer.
British journal of cancer 2000;83(9):1128-35.
2000: Jean Klastersky
Empirical treatment of sepsis in neutropenic patients.
International journal of antimicrobial agents 2000;16(2):131-3.
2000: Jean Klastersky; M Paesmans; Edward B Rubenstein; M Boyer; Linda S Elting; R Feld; J Gallagher; J Herrstedt; B Rapoport; Kenneth Rolston; J Talcott
The Multinational Association for Supportive Care in Cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(16):3038-51.
2000: Marianne Paesmans; Jean-Paul Sculier; J Lecomte; J Thiriaux; P Libert; R Sergysels; G Bureau; G Dabouis; O Van Cutsem; P Mommen; Vincent Ninane; Jean Klastersky
Prognostic factors for patients with small cell lung carcinoma: analysis of a series of 763 patients included in 4 consecutive prospective trials with a minimum follow-up of 5 years.
Cancer 2000;89(3):523-33.
2000: Jean-Paul Sculier; Jean-Jacques Lafitte; Thierry Berghmans; J Thiriaux; J Lecomte; Anna P Efremidis; Vincent Ninane; Marianne Paesmans; P Mommen; Jean Klastersky
A phase II trial testing gemcitabine as second-line chemotherapy for non small cell lung cancer. The European Lung Cancer Working Party. 101473.1044@compuserve.com.
Lung cancer (Amsterdam, Netherlands) 2000;29(1):67-73.
1999: Thierry Berghmans; Jean Klastersky; Eveline Markiewicz; P Mommen; Jean-Paul Sculier
Cisplatin-carboplatin-gemcitabine or ifosfamide-gemcitabine in advanced non-small cell lung carcinoma: two pilot studies.
Anticancer research 1999;19(6C):5651-5.
1999: Jean-Paul Sculier; Vincent Ninane; Anna P Efremidis; Jean-Jacques Lafitte; P van Houtte; CG Alexopoulos; J Thiriaux; Jean Klastersky
The first World Conference on Clinical Cooperative Research for Lung Cancer, Brussels 4-6 March 1999.
Lung cancer (Amsterdam, Netherlands) 1999;26(2):113-6.
1999: Jean-Paul Sculier; Marianne Paesmans; J Thiriaux; J Lecomte; G Bureau; V Giner; George Koumakis; Jean-Jacques Lafitte; MC Berchier; CG Alexopoulos; Constantinos Zacharias; P Mommen; Vincent Ninane; Jean Klastersky
A comparison of methods of calculation for estimating carboplatin AUC with a retrospective pharmacokinetic-pharmacodynamic analysis in patients with advanced non-small cell lung cancer. European Lung Cancer Working Party.
European journal of cancer (Oxford, England : 1990) 1999;35(9):1314-9.
1999: Jean-Paul Sculier; Marianne Paesmans; Jean-Jacques Lafitte; J Baumöhl; J Thiriaux; O Van Cutsem; P Recloux; G Bureau; MC Berchier; Constantinos Zacharias; P Mommen; T Bosschaerts; Thierry Berghmans; P van Houtte; Vincent Ninane; Jean Klastersky
A randomised phase III trial comparing consolidation treatment with further chemotherapy to chest irradiation in patients with initially unresectable locoregional non-small-cell lung cancer responding to induction chemotherapy. European Lung Cancer Working Party.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(3):295-303.
1998: Jean-Paul Sculier; Marianne Paesmans; Vincent Ninane; V Giner; G Bureau; Jean-Jacques Lafitte; J Baumöhl; J Thiriaux; O Van Cutsem; P Recloux; MC Berchier; Constantinos Zacharias; P Mommen; P van Houtte; Jean Klastersky
Evaluation of the TN sub-staging in patients with initially unresectable stage III non-small cell lung cancer treated by induction chemotherapy. The European Lung Cancer Working Party.
Lung cancer (Amsterdam, Netherlands) 1998;22(3):201-13.
1998: Mickael Aoun; Françoise Crokaert; Marianne Paesmans; P Autier; Jean Klastersky
Imipenem versus targeted therapy in cancer patients.
International journal of antimicrobial agents 1998;10(4):263-70.
1998: Jean Klastersky
Science and pragmatism in the treatment and prevention of neutropenic infection.
The Journal of antimicrobial chemotherapy 1998;41 Suppl D():13-24.
1998: Jean-Paul Sculier; Marianne Paesmans; J Thiriaux; J Lecomte; G Bureau; V Giner; Anna P Efremidis; Jean-Jacques Lafitte; MC Berchier; CG Alexopoulos; Constantinos Zacharias; P Mommen; Vincent Ninane; Jean Klastersky
Phase III randomized trial comparing cisplatin and carboplatin with or without ifosfamide in patients with advanced non-small-cell lung cancer. European Lung Cancer Working Party.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(4):1388-96.
1998: C Sotiriou; P van Houtte; Jean Klastersky
Lung fibrosis induced by paclitaxel.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 1998;6(1):68-71.
1997: Marianne Paesmans; Jean-Paul Sculier; P Libert; G Bureau; G Dabouis; J Thiriaux; J Michel; O Van Cutsem; R Sergysels; P Mommen; Jean Klastersky
Response to chemotherapy has predictive value for further survival of patients with advanced non-small cell lung cancer: 10 years experience of the European Lung Cancer Working Party.
European journal of cancer (Oxford, England : 1990) 1997;33(14):2326-32.
1997: Jean-Paul Sculier; Marianne Paesmans; P Libert; G Bureau; G Dabouis; J Thiriaux; J Michel; O Van Cutsem; J Schmerber; V Giner; MC Berchier; P Mommen; R Sergysels; Jean Klastersky
[Prognostic factors in advanced stage non-small cell bronchial cancer: experiences of the European Lung Cancer Working Party].
Revue des maladies respiratoires 1997;14(6):445-9.
1997: Jean Klastersky; A Awada
[Gemcitabine: a new chemotherapy agent for solid cancers].
Revue médicale de Bruxelles 1997;18(5):328-34.
1997: Jean Klastersky
[Febrile neutropenia: empiric antibiotic therapy from 1975 to 1997].
Revue médicale de Bruxelles 1997;18(5):323-7.
1997: Jean Klastersky
Treatment of neutropenic infection: trends towards monotherapy?
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 1997;5(5):365-70.
1996: M Borges; Jean-Paul Sculier; Marianne Paesmans; M Richez; G Bureau; G Dabouis; J Lecomte; J Michel; O Van Cutsem; J Schmerber; V Giner; MC Berchier; R Sergysels; P Mommen; Jean Klastersky
Prognostic factors for response to chemotherapy containing platinum derivatives in patients with unresectable non-small cell lung cancer. (NSCLC).
Lung cancer (Amsterdam, Netherlands) 1996;16(1):21-33.
1996: F Crokaert; M Aoun; V Duchateau; P Grenier; A Vandermies; Jean Klastersky
In vitro activity of trovafloxacin (CP-99,219), sparfloxacin, ciprofloxacin, and fleroxacin against respiratory pathogens.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1996;15(8):696-8.
1996: Jean-Paul Sculier; Marianne Paesmans; G Bureau; V Giner; J Lecomte; J Michel; MC Berchier; O Van Cutsem; U Küstner; F Kroll; R Sergysels; P Mommen; Jean Klastersky
Randomized trial comparing induction chemotherapy versus induction chemotherapy followed by maintenance chemotherapy in small-cell lung cancer. European Lung Cancer Working Party.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(8):2337-44.
1996: Alain Cometta; T Calandra; H Gaya; S H Zinner; R de Bock; A Del Favero; Giampaolo Bucaneve; F Crokaert; Winfried V Kern; Jean Klastersky; I Langenaeken; Alessandra Micozzi; A Padmos; Marianne Paesmans; Claudio Viscoli; Michel-Pierre Glauser
Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto Infection Program.
Antimicrobial agents and chemotherapy 1996;40(5):1108-15.
1995: Jean Klastersky; Jean-Paul Sculier
Dose-finding study of paclitaxel (Taxol) plus cisplatin in patients with non-small cell lung cancer. European Lung Cancer Working Party.
Lung cancer (Amsterdam, Netherlands) 1995;12 Suppl 2():S117-25.
1995: Jean Klastersky
Therapy of non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 1995;12 Suppl 1():S133-45.
1995: Alain Cometta; S Zinner; R de Bock; T Calandra; H Gaya; Jean Klastersky; J Langenaeken; Marianne Paesmans; Claudio Viscoli; Michel-Pierre Glauser
Piperacillin-tazobactam plus amikacin versus ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer.
Antimicrobial agents and chemotherapy 1995;39(2):445-52.
1994: Jean Klastersky; Jean-Paul Sculier; F Ries; G Dabouis; P Libert; J Schmerber; J Thiriaux; MC Berchier; G Bureau; O Van Cutsem
A four-drug combination chemotherapy with cisplatin, mitomycin, vindesine and 5 fluorouracile: a regimen associated with major toxicity in patients with advanced non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 1994;11(5-6):373-84.
1994: R Feld; M Borges; V Giner; R Ginsberg; P Harper; Jean Klastersky; L Lacquet; Marianne Paesmans; D Payne; R Rosell
Prognostic factors in non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 1994;11 Suppl 3():S19-23.
1994: Jean Klastersky; Jean-Paul Sculier
Dose-finding study of paclitaxel (Taxol) plus cisplatin in patients with non-small cell lung cancer.
Seminars in oncology 1994;21(5 Suppl 8):39-43.
1994: Jean Klastersky; Jean-Paul Sculier; F Ries; G Dabouis; P Libert; J Schmerber; J Thiriaux; MC Berchier; G Bureau; O Van Cutsem
A four-drug combination chemotherapy with cisplatin, mitomycin, vindesine and 5-fluorouracil. A regimen associated with major toxicity in patients with advanced non-small lung cancer. European Lung Cancer Working Party.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5(7):641-3.
1994: Jean-Paul Sculier; Jean Klastersky; V Giner; G Bureau; J Thiriaux; G Dabouis; Anna P Efremidis; F Ries; MC Berchier; R Sergysels
Phase II randomized trial comparing high-dose cisplatin with moderate-dose cisplatin and carboplatin in patients with advanced non-small-cell lung cancer. European Lung Cancer Working Party.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(2):353-9.
1994: Claudio Viscoli; P Bruzzi; Elio Castagnola; L Boni; T Calandra; H Gaya; F Meunier; R Feld; S Zinner; Jean Klastersky
Factors associated with bacteraemia in febrile, granulocytopenic cancer patients. The International Antimicrobial Therapy Cooperative Group (IATCG) of the European Organization for Research and Treatment of Cancer (EORTC).
European journal of cancer (Oxford, England : 1990) 1994;30A(4):430-7.
1993: Jean Klastersky
Febrile neutropenia.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 1993;1(5):233-9.
1993: Jean Klastersky
Fever and neutropenia during intensive chemotherapy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1993;4(7):603-6.
1993: Jean Klastersky
[Should inoperable pulmonary cancer be treated?].
Revue médicale de Bruxelles 1993;14(4):102-9.
1992: Thierry Berghmans; Jean Klastersky
[Small-cell lung cancer: survival analysis over the last 10 years: 1980-1990].
Revue médicale de Bruxelles 1992;13(8):279-81, 284-5.
1992: A Awada; Jean Klastersky
[Multiple neoplasms: etiological problems and possibilities for prevention].
Revue médicale de Bruxelles 1992;13(7):239-42.
1992: J J Body; Marianne Paesmans; Jean-Paul Sculier; G Dabouis; G Bureau; P Libert; MC Berchier; N Raymakers; Jean Klastersky
Monoclonal immunoradiometric assay and polyclonal radioimmunoassay compared for measuring neuron-specific enolase in patients with lung cancer.
Clinical chemistry 1992;38(5):748-51.
1991: F Meunier; S H Zinner; H Gaya; T Calandra; Claudio Viscoli; Jean Klastersky; Michel-Pierre Glauser
Prospective randomized evaluation of ciprofloxacin versus piperacillin plus amikacin for empiric antibiotic therapy of febrile granulocytopenic cancer patients with lymphomas and solid tumors. The European Organization for Research on Treatment of Cancer International Antimicrobial Therapy Cooperative Group.
Antimicrobial agents and chemotherapy 1991;35(5):873-8.
1990: Jean Klastersky; Jean-Paul Sculier; H Lacroix; G Dabouis; G Bureau; P Libert; M Richez; P Ravez; G Vandermoten; J Thiriaux
A randomized study comparing cisplatin or carboplatin with etoposide in patients with advanced non-small-cell lung cancer: European Organization for Research and Treatment of Cancer Protocol 07861.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(9):1556-62.
1990: Jean Klastersky
Empiric treatment of infection during granulocytopenia.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1990;1(4):255-61.
1990: Jean Klastersky; Jean-Paul Sculier; G Dabouis; G Bureau; P Libert; P Ravez; G Vandermoten; J Thiriaux; J Lecomte; R Cordier
A randomized trial of two platinum combinations in patients with advanced non-small cell lung cancer: a preliminary report. European Organization for the Research and Treatment of Cancer--Lung Cancer Working Party.
Seminars in oncology 1990;17(1 Suppl 2):20-4.
1990: Jean-Paul Sculier; Jean Klastersky; P Libert; P Ravez; D Brohee; G Vandermoten; J Michel; J Thiriaux; G Bureau; J Schmerber
Cyclophosphamide, doxorubicin and vincristine with amphotericin B in sonicated liposomes as salvage therapy for small cell lung cancer.
European journal of cancer (Oxford, England : 1990) 1990;26(8):919-21.
1990: W Schroyens; E Tueni; P Dodion; R Bodecker; F Stoessel; Jean Klastersky
Validation of clinical predictive value of in vitro colorimetric chemosensitivity assay in head and neck cancer.
European journal of cancer (Oxford, England : 1990) 1990;26(7):834-8.
1990: Jean-Paul Sculier; Jean Klastersky; P Libert; P Ravez; J Thiriaux; J Lecomte; G Bureau; G Vandermoten; G Dabouis; J Michel
A randomized study comparing etoposide and vindesine with or without cisplatin as induction therapy for small cell lung cancer. EORTC Lung Cancer Working Party.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1990;1(2):128-33.
1989: D Bron; Jean Klastersky
Immunoprophylaxis of cytomegalovirus infections in transplanted patients.
European journal of cancer & clinical oncology 1989;25(9):1365-8.
1989: Jean Klastersky; Jean-Paul Sculier; G Bureau; P Libert; P Ravez; G Vandermoten; J Thiriaux; J Lecomte; R Cordier; G Dabouis
Cisplatin versus cisplatin plus etoposide in the treatment of advanced non-small-cell lung cancer. Lung Cancer Working Party, Belgium.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1989;7(8):1087-92.
1988: M Gerard; F Meunier; P Dor; Guy Andry; G Chantrain; P Van der Auwera; D Daneau; Jean Klastersky
Antimicrobial prophylaxis for major head and neck surgery in cancer patients.
Antimicrobial agents and chemotherapy 1988;32(10):1557-9.
1988: V Richard; F Meunier; P Van der Auwera; P Dejace; D Daneau; Jean Klastersky
Pneumococcal bacteremia in cancer patients.
European journal of epidemiology 1988;4(2):242-5.
1988: Jean Klastersky
Cisplatin and carboplatin in combination with etoposide as a treatment for non-small cell lung cancer: the experience of the EORTC Lung Cancer Working Party.
Cancer treatment reviews 1988;15 Suppl B():33-40.
1988: F Meunier; Jean Klastersky
Recent developments in prophylaxis and therapy of invasive fungal infections in granulocytopenic cancer patients.
European journal of cancer & clinical oncology 1988;24(3):539-44.
1988: Jean-Paul Sculier; Jean Klastersky; D Becquart; G Vandermoten; P van Houtte; P Rocmans; J Thiriaux; E Longeval; P Ravez; P Libert
Phase II study of an intensive combination chemotherapy with cisplatin, adriamycin, etoposide and cyclophosphamide (CAVE) in small cell lung cancer.
European journal of cancer & clinical oncology 1988;24(3):519-26.
1988: Jean Klastersky; S H Zinner; T Calandra; H Gaya; Michel-Pierre Glauser; F Meunier; M Rossi; Stephen C Schimpff; M Tattersall; Claudio Viscoli
Empiric antimicrobial therapy for febrile granulocytopenic cancer patients: lessons from four EORTC trials.
European journal of cancer & clinical oncology 1988;24 Suppl 1():S35-45.
1988: P Van der Auwera; M Husson; Jean Klastersky
Bactericidal activity and killing rate of serum in volunteers receiving pefloxacin alone or in combination with ceftazidime, piperacillin or mezlocillin against Pseudomonas aeruginosa.
The Journal of antimicrobial chemotherapy 1988;21(1):49-55.
1988: P van Houtte; Jean Klastersky; A Renaud; J Michel; G Vandermoten; H Nguyen; Jean-Paul Sculier; J Devriendt; P Mommen
Induction chemotherapy with cisplatin, etoposide and vindesine before radiation therapy for nonsmall-cell lung cancer. A randomized study.
Antibiotics and chemotherapy 1988;41():131-7.
1987: Elias Tueni; P Dumont; D Jacobovitz; G Atassi; P Rocmans; F Lejeune; P de Franquen; P Semal; Jean Klastersky
Subrenal capsule assay for fresh human tumors in immunocompetent mice; an inappropriate technique for non-small cell lung cancer.
European journal of cancer & clinical oncology 1987;23(8):1163-7.
1987: P Dejace; Jean Klastersky
[A comparative review of combination therapy: 2 beta-lactams versus beta-lactam plus aminoglycoside].
Infection 1987;15 Suppl 4():S158-67.
1986: Jean Klastersky; Jean-Paul Sculier; P Ravez; P Libert; J Michel; G Vandermoten; P Rocmans; Y Bonduelle; M Mairesse; T Michiels
A randomized study comparing a high and a standard dose of cisplatin in combination with etoposide in the treatment of advanced non-small-cell lung carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1986;4(12):1780-6.
1986: J Abrams; D Jacobovitz; P Dumont; P Semal; P Mommen; Jean Klastersky; G Atassi
Subrenal capsule assay of fresh human tumors: problems and pitfalls.
European journal of cancer & clinical oncology 1986;22(11):1387-94.
1986: Jean-Paul Sculier; Jean Klastersky; J P Dumont; G Vandermoten; P Rocmans; P Libert; P Ravez; D Becquart; P Mommen; O Dalesio
Combination chemotherapy with mitomycin and vindesine in advanced non-small cell lung cancer: a pilot study by the Lung Cancer Working Party (Belgium).
Cancer treatment reports 1986;70(6):773-5.
1985: Jean Klastersky; Jean-Paul Sculier; J P Dumont; D Becquart; G Vandermoten; P Rocmans; J Michel; E Longeval; O Dalesio
Combination chemotherapy with adriamycin, etoposide, and cyclophosphamide for small cell carcinoma of the lung. A study by the EORTC Lung Cancer Working Party (Belgium).
Cancer 1985;56(1):71-5.
1983: Jean Klastersky; Jean-Paul Sculier; C Nicaise; D Weerts; M Mairesse; P Libert; P Rocmans; J Michel; W Ferremans
Combination chemotherapy with cisplatin, etoposide, and vindesine in non-small cell lung carcinoma: a clinical trial of the EORTC lung cancer working party.
Cancer treatment reports 1983;67(7-8):727-30.
1982: Jean Klastersky; C Nicaise; E Longeval; P Stryckmans
Cisplatin, adriamycin, and etoposide (CAV) for remission induction of small-cell bronchogenic carcinoma.
Cancer 1982;50(4):652-8.
1982: Jean Klastersky; E Longeval; C Nicaise; D Weerts
Etoposide and cis-platinum in non-small-cell bronchogenic carcinoma.
Cancer treatment reviews 1982;9 Suppl():133-8.